12/12
04:05 pm
gri
GRI Bio Announces Closing of $8.0 Million Public Offering
Medium
Report
GRI Bio Announces Closing of $8.0 Million Public Offering
12/11
09:15 am
gri
GRI Bio Announces Pricing of $8,000,000 Million Public Offering
High
Report
GRI Bio Announces Pricing of $8,000,000 Million Public Offering
12/10
04:05 pm
gri
GRI Bio Announces Positive Topline Data from its Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
High
Report
GRI Bio Announces Positive Topline Data from its Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
12/8
08:07 am
gri
GRI Bio (NASDAQ:GRI) had its price target raised by analysts at Ascendiant Capital Markets from $35.00 to $36.00. They now have a "buy" rating on the stock.
High
Report
GRI Bio (NASDAQ:GRI) had its price target raised by analysts at Ascendiant Capital Markets from $35.00 to $36.00. They now have a "buy" rating on the stock.